Profitability
This table compares Acutus Medical and NEXGEL’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Acutus Medical | -272.74% | -311.64% | -11.57% |
| NEXGEL | -52.60% | -71.19% | -34.79% |
Risk and Volatility
Acutus Medical has a beta of -0.22, suggesting that its stock price is 122% less volatile than the S&P 500. Comparatively, NEXGEL has a beta of 0.76, suggesting that its stock price is 24% less volatile than the S&P 500.
Insider and Institutional Ownership
56.9% of Acutus Medical shares are held by institutional investors. Comparatively, 2.2% of NEXGEL shares are held by institutional investors. 5.2% of Acutus Medical shares are held by insiders. Comparatively, 24.9% of NEXGEL shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Valuation and Earnings
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Acutus Medical | $7.16 million | 0.27 | -$81.66 million | N/A | N/A |
| NEXGEL | $4.09 million | 7.82 | -$3.16 million | ($0.58) | -8.12 |
NEXGEL has lower revenue, but higher earnings than Acutus Medical.
Summary
NEXGEL beats Acutus Medical on 6 of the 9 factors compared between the two stocks.
About Acutus Medical
Acutus Medical, Inc. designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California.
About NEXGEL
NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. The company was incorporated in 2009 and is based in Langhorne, Pennsylvania.
Receive News & Ratings for Acutus Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acutus Medical and related companies with MarketBeat.com's FREE daily email newsletter.
